Zealand Pharma AS (ZLDPF)
115.06
-1.00
(-0.86%)
USD |
OTCM |
Nov 14, 09:32
Zealand Pharma Total Liabilities (Quarterly): 111.84M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 111.84M |
| June 30, 2024 | 109.03M |
| March 31, 2024 | 108.32M |
| December 31, 2023 | 57.48M |
| September 30, 2023 | 50.80M |
| June 30, 2023 | 47.02M |
| March 31, 2023 | 97.68M |
| December 31, 2022 | 104.19M |
| September 30, 2022 | 95.85M |
| June 30, 2022 | 105.52M |
| March 31, 2022 | 169.22M |
| December 31, 2021 | 173.52M |
| September 30, 2021 | 74.10M |
| June 30, 2021 | 86.01M |
| March 31, 2021 | 79.92M |
| December 31, 2020 | 88.04M |
| September 30, 2020 | 73.97M |
| June 30, 2020 | 71.18M |
| March 31, 2020 | 51.13M |
| December 31, 2019 | 52.04M |
| September 30, 2019 | 44.61M |
| June 30, 2019 | 40.01M |
| March 31, 2019 | 40.01M |
| December 31, 2018 | 17.39M |
| September 30, 2018 | 43.92M |
| Date | Value |
|---|---|
| June 30, 2018 | 31.94M |
| March 31, 2018 | 30.33M |
| December 31, 2017 | 33.30M |
| September 30, 2017 | 30.02M |
| June 30, 2017 | 30.70M |
| March 31, 2017 | 31.82M |
| December 31, 2016 | 59.22M |
| September 30, 2016 | 52.99M |
| June 30, 2016 | 55.31M |
| March 31, 2016 | 54.17M |
| December 31, 2015 | 56.24M |
| September 30, 2015 | 56.76M |
| June 30, 2015 | 53.18M |
| March 31, 2015 | 52.20M |
| December 31, 2014 | 56.15M |
| September 30, 2014 | 7.083M |
| June 30, 2014 | 6.173M |
| March 31, 2014 | 6.752M |
| December 31, 2013 | 5.696M |
| September 30, 2013 | 4.331M |
| June 30, 2013 | 6.410M |
| March 31, 2013 | 4.882M |
| December 31, 2012 | 5.563M |
| September 30, 2012 | 4.748M |
| June 30, 2012 | 3.670M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
47.02M
Minimum
Jun 2023
173.52M
Maximum
Dec 2021
90.34M
Average
87.02M
Median
Total Liabilities (Quarterly) Benchmarks
| Novo Nordisk AS | 41.48B |
| Genmab AS | 1.159B |
| Ascendis Pharma AS | 1.157B |
| Galecto Inc | 2.441M |
| Evaxion Biotech AS | 15.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.442B |
| Shareholders Equity (Quarterly) | 1.331B |
| Debt to Equity Ratio | 0.0316 |
| Current Ratio | 35.49 |
| Net Debt Paydown Yield | -0.10% |